This week, the FDA granted priority review status to J&J’s JNJ application seeking approval of key pipeline candidate ...

Developers are now working on new versions and improving the results of artificial intelligence.

Bagsværd, Denmark Friday, January 10, 2025, 11:00 Hrs [IST] ...

Johnson & Johnson received Priority Review of nipocalimab in generalized myasthenia gravis. GSK’s B7-H3-targeted ...

Shares of Novo Nordisk NVO gained 2.8% on Wednesday likely because the analysts at UBS upgraded the company’s rating from ...